Texas Medical Center Innovation (TMCi)
TMC Innovation Accelerator for Cancer Therapeutics (ACT)
TMC Innovation Accelerator for Cancer Therapeutics (ACT) is a funding opportunity from Texas Medical Center Innovation (TMCi).
Overview
A nine-month, CPRIT-funded, no-equity program for Texas-based cancer-therapeutics investigators and biotech companies, pairing them with mentors toward an investor pitch and grant submission.